Author

Quang Toan Pham

Centre Hospitalier Universitaire Sainte-Justine

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Developmental Biology· 1 Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Research Focus:differential expression· 1 Organism:mouse· 1 Assay:organoid / primary culture· 1

Frequent Co-Authors

C. Casini RaggiiD· 3 shared Marie-Agnès M’Callum· 3 shared Massimiliano PaganelliiD· 3 shared Chenicka Lyn Mangahas· 2 shared Nissan Baratang· 2 shared Silvia Selleri· 2 shared Yves ThéorêtiD· 2 shared Basma Benabdallah· 1 shared

Activity by Year

2020-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 42 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersBioengineering

C. Casini RaggiORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Off-the-Shelf Engineered Liver Tissue Reverses Acute Liver Failure Without Immunosuppression

C. Casini Raggi, Pascal Lapierre, Marie-Agnès M’Callum, Quang Toan Pham, Silvia Selleri, Radu Alexandru Paun, Nissan Baratang, Chenicka Lyn Mangahas, Basma Benabdallah, Gaël Moquin‐Beaudry, Jiwoon Park, Dorothée Bouron Dal Soglio, Yves Théorêt, Robert E. Schwartz, Christian M. Beausejour, , Massimiliano Paganelli

This paper describes engineered liver tissue that reverses acute liver failure in mice without immunosuppression, demonstrating potential for clinical translation.

bioRxiv · Oct 8, 2025 · PreprintBioengineering

NTBC dosing and outcomes in hereditary tyrosinemia type 1: insights from a representative human model and 99 patients

Quang Toan Pham, Farzaneh Tamnanloo, Marie-Agnès M’Callum, E Beaulieu, Rasha Mghabghab, Yves Théorêt, Grant A. Mitchell, the Quebec NTBC Study Group, Denis Cyr, Paula J. Waters, Y Doyon, Ugur Halac, C. Casini Raggi, Massimiliano Paganelli

This study identifies the minimal effective NTBC dose to prevent liver damage in HT1 using an in vitro model and validates it in 99 patients, while highlighting residual gene dysregulation linked to cancer risk.

bioRxiv · Oct 6, 2025 · PreprintGenetics

Leveraging complex interactions between signaling pathways involved in liver development to robustly improve the maturity and yield of pluripotent stem cell-derived hepatocytes

C. Casini Raggi, Marie-Agnès M’Callum, Quang Toan Pham, Perrine Gaub, Silvia Selleri, Nissan Baratang, Chenicka Lyn Mangahas, Gaël Cagnone, Bruno Reversade, Jean‐Sébastien Joyal, Massimiliano Paganelli

bioRxiv · Sep 2, 2020 · PreprintDevelopmental Biology